AlphaFold predicted structure
FGF9 · P31371

Mean pLDDT
82.8/ 100
Confident
208 residues
Confidence breakdown
- Very high(≥ 90)64%
- Confident(70–90)9%
- Low(50–70)9%
- Very low(< 50)18%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
fibroblast growth factor 9
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownRare syndromic craniosynostosis or isolated multisuture synostosis
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedSkeletal dysplasia
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedLimb disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownmultiple synostoses syndrome
cancer
bone development disease
female reproductive endometrioid cancer
ovarian carcinoma
craniosynostosis
acrocephalosyndactyly
hypertensive disorder
open-angle glaucoma
essential hypertension
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Fibroblast growth factor 9
Plays an important role in the regulation of embryonic development, cell proliferation, cell differentiation and cell migration. May have a role in glial cell growth and differentiation during development, gliosis during repair and regeneration of brain tissue after damage, differentiation and survival of neuronal cells, and growth stimulation of glial tumors
FGF9 · P31371

Mean pLDDT
82.8/ 100
Confident
208 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0